MEDIVIR AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.05 SEK | +10.51% |
|
+13.81% | +7.02% |
| Apr. 25 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
| Mar. 21 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Evolution of the average Target Price on Medivir AB
Price target over the last 5 years
History of analyst recommendation changes
c6a0542e9b3fa147f8ab7406b3d3.e9bWkt0LMqW5dqLf_c7HW5E77wtiodSuY36Vok1IXMs.NZfn_ZVPY_zRHfrotbq2I9hSqG8s94fIWg3AmnsJPakuvrTUhGhbkeYOwQ~28905f25807446760cdacb3103e7e4f6
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.05
SEK
Average target price
20.55
SEK
Spread / Average Target
+573.91%
High Price Target
54
SEK
Spread / Highest target
+1,670.49%
Low Price Target
7.75
SEK
Spread / Lowest Target
+154.10%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- MVIR B Stock
- Consensus Medivir AB
